The interpersonal adverse effects reported by 1008 users of antidepressants; and the incremental impact of polypharmacy

[1]  J. Jakobsen,et al.  Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis , 2017, BMC Psychiatry.

[2]  J. Read,et al.  Do GPs and psychiatrists recommend alternatives when prescribing anti-depressants? , 2016, Psychiatry Research.

[3]  S. Kapur,et al.  Initial depression severity and response to antidepressants v. placebo: patient-level data analysis from 34 randomised controlled trials , 2016, British Journal of Psychiatry.

[4]  J. Read,et al.  ‘In my life antidepressants have been…’: a qualitative analysis of users’ diverse experiences with antidepressants , 2016, BMC Psychiatry.

[5]  C. Davey,et al.  The unfulfilled promise of the antidepressant medications , 2016, The Medical journal of Australia.

[6]  J. Read,et al.  Are older people prescribed antidepressants on the basis of fewer symptoms of depression, and for longer periods of time? A survey of 1825 New Zealanders , 2016, Australasian journal on ageing.

[7]  Jennifer S. Haas,et al.  Trends in Prescription Drug Use Among Adults in the United States From 1999–2012 , 2016 .

[8]  W. Brown,et al.  Antidepressants versus placebo in major depression: an overview , 2015, World psychiatry : official journal of the World Psychiatric Association.

[9]  J. Moncrieff.  Antidepressants: misnamed and misrepresented , 2015, World psychiatry : official journal of the World Psychiatric Association.

[10]  J. Read,et al.  Understanding the non-pharmacological correlates of self-reported efficacy of antidepressants , 2015, Acta psychiatrica Scandinavica.

[11]  J. Read,et al.  Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants , 2014, Psychiatry Research.

[12]  J. Read,et al.  Patient-Centered Perspectives on Antidepressant Use , 2014 .

[13]  N. Shah,et al.  Polypharmacy In Psychiatry: A Review , 2013, Mens sana monographs.

[14]  E. J. van den Oord,et al.  Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D , 2012, Translational Psychiatry.

[15]  J. Moncrieff,et al.  Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. , 2012, The British journal of psychiatry : the journal of mental science.

[16]  J. Moncrieff,et al.  The psychoactive effects of antidepressants and their association with suicidality. , 2011, Current drug safety.

[17]  E. Spina,et al.  Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study , 2011, Schizophrenia Research.

[18]  F. Besag.  Adverse effects, adverse events and side-effects: does the terminology matter? , 2011, Current drug safety.

[19]  M. Olfson,et al.  National trends in psychotropic medication polypharmacy in office-based psychiatry. , 2010, Archives of general psychiatry.

[20]  G. Goodwin,et al.  Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. , 2009, The British journal of psychiatry : the journal of mental science.

[21]  Marcella Rietschel,et al.  Adverse reactions to antidepressants. , 2009, The British journal of psychiatry : the journal of mental science.

[22]  M. Olfson,et al.  National patterns in antidepressant medication treatment. , 2009, Archives of general psychiatry.

[23]  N. Gavey,et al.  "I Didn't Just Cross a Line I Tripped over an Edge": Experiences of Serious Adverse Effects with Selective Serotonin Reuptake Inhibitor Use , 2008 .

[24]  Blair T. Johnson,et al.  Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration , 2008, PLoS medicine.

[25]  J. Davis-berman,et al.  Taking anti-depressant medication: A qualitative examination of internet postings , 2008 .

[26]  D. Oslin,et al.  Older patients’ aversion to antidepressants , 2006, Journal of General Internal Medicine.

[27]  S. Preskorn,et al.  Guide to Psychiatric Drug Interactions , 2006 .

[28]  E. Sanz,et al.  Polypharmacy in psychiatric practice in the Canary Islands , 2004, BMC psychiatry.

[29]  W. Brown,et al.  Are placebo controls necessary to test new antidepressants and anxiolytics? , 2002, The international journal of neuropsychopharmacology.

[30]  H. Rittmannsberger.  The use of drug monotherapy in psychiatric inpatient treatment , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.